Inhaled Levodopa May Rapidly Relieve Parkinson's Symptoms

Share this content:
Inhaled Levodopa May Rapidly Relieve Parkinson's Symptoms
Inhaled Levodopa May Rapidly Relieve Parkinson's Symptoms

THURSDAY, Oct. 13, 2016 (HealthDay News) -- An inhaled version of the Parkinson's drug levodopa can help when patients experience symptoms between doses of the pill form of the medication, according to a study published in the Oct. 12 issue of Science Translational Medicine.

Michael Lipp, Ph.D., the vice president of pharmaceutical development and technical operations at Acorda Therapeutics, the drug's maker and funder of the study, and colleagues tested the powdered version of levodopa in dogs, 18 people without Parkinson's, and 24 Parkinson's patients who had at least two off hours a day despite taking levodopa pills.

The inhaled drug was rapidly absorbed and was detectable in the bloodstream within five minutes, compared with 20 minutes after taking levodopa orally, the researchers found. Parkinson's patients showed improved motor function after inhaling the drug. The drug appeared safe and was well tolerated. Coughing was the most common side effect.

"Off periods are considered one of the greatest unmet medical needs in the treatment of Parkinson's, and typically increase in frequency during the course of the disease," Lipp told HealthDay. "We're studying inhaled levodopa to determine the extent to which it can restore motor function when used as people begin to experience off periods."

Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

USPSTF Urges Abuse Screening for Reproductive-Aged Women

USPSTF Urges Abuse Screening for Reproductive-Aged Women

Evidence lacking for assessing balance of benefits, harms of screening for abuse of seniors, vulnerable

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Five-Day Nitrofurantoin Beats Single-Dose Fosfomycin for UTI

Increased likelihood of clinical and microbiological resolution for uncomplicated UTI in women

Exercise Intervention Doesn't Improve Walking Ability in PAD

Exercise Intervention Doesn't Improve Walking Ability in PAD

Smaller mean change from baseline to follow-up in 6-minute walking distance with exercise intervention

is free, fast, and customized just for you!

Already a member?

Sign In Now »